Nephro Care India Limited ("NCIL" or "The Company"), a leading multi-speciality healthcare provider in East India, has successfully completed its Anchor book subscription, raising Rs. 11.14 crore through the sale of 12.38 Lakh equity shares priced at Rs. 90/- each.
A group of marquee investors subscribed to the anchor book, including CCV Emerging Opportunities Fund - I, Persistent Growth Fund - Varsu India Growth Story Scheme 1 and Vikasa India EIF I Fund - Incube Global Opportunities.
CCV Emerging Opportunities Fund I subscribed to 62.92% of the anchor book, Persistent Growth Fund - Varsu India Growth Story Scheme 1 and Vikasa India EIF Fund Incube Global Opportunities subscribed to 28.04% and 9.04%, respectively.
The Kolkata-based healthcare provider's IPO begins today, June 28, and will conclude on Tuesday, July 02, 2024. Nephro Care India Limited is looking to raise approximately Rs. 41.26 crore from the offering. The company intends to utilise Rs. 26.17 crore of net proceeds from the IPO to set up a multi-speciality healthcare facility, 'Vivacity Multi Speciality Hospital', at Madhyamgaram in Kolkata, West Bengal, and the company plans to use the remaining capital for general corporate purposes. The new hospital will be a unit of Nephro Care India Limited and is proposed to include 100 inpatient beds, including a 30-bed Critical Care unit having ICU, HDU, RTU and NICU facilities. Vivacity will offer treatment services in various disciplines such as cardiology, medical oncology, gastroenterology, gynaecology and many others, including an advanced renal transplant unit in East India.
The price band of the issue is Rs. 85-90/- per equity share with a face value of Rs. 10/- apiece. The company's IPO comprises a fresh issue of 45.84 lakh Equity Shares with a face value of Rs. 10/- through the book-building route. Corporate Capital Ventures Private Limited is the sole Book Running Lead Manager to the Issue, and Bigshare Services Private Limited is the Registrar.
The company has allotted 12.38 Lakh equity shares for the Anchor investors, 2.3 Lakh equity shares for the market maker, 2.25 Lakh equity shares reserved for the employees, 6.19 Lakh equity shares allocated for the HNI portion, 8.25 Lakh equity shares for net QIBs, and the Retail (RII) portion accounts for 14.44 Lakh equity shares.
Nephro Care was founded in the year 2021 by one of the leading nephrologists in India, Dr. Pratim Sengupta, in Kolkata, with the objective of providing comprehensive medical services for renal patients. With over 20 years of active clinical experience, Dr. Sengupta, has successfully performed more than 1,000 kidney transplants till now and is a pioneer in holistic renal care through a combination of clinical intervention, yoga and lifestyle support. Dr. Sengupta has been awarded the "Bharat Jyoti Award" for meritorious services, outstanding achievement and remarkable role by the India International Friendship Society in 2019. |
